Nav: Home

Mayo clinic first to implant device to solve fecal incontinence

June 07, 2016

JACKSONVILLE, Fla. -- A clinical team on Mayo Clinic's Florida campus is the first to offer four patients with long-term fecal incontinence a new and potentially long-lasting treatment -- a small band of interlinked magnetic titanium beads on a titanium string that successfully mimics the function of the anal sphincter.

At this point, Mayo Clinic is the only medical center that has surgically implanted this device, known as the Fenix Continence Restoration System. In December 2015, the system received U.S. Food and Drug Administration approval under a humanitarian device exemption, which requires approval for patient use by a hospital's Institutional Review Board (IRB). The IRB at Mayo Clinic is the first and, as yet, the only center to approve use of the device.

The issue of fecal incontinence, or accidental bowel leakage, is not unusual. It can affect more than 20 percent of women over 45, says Paul Pettit, M.D., a female pelvic medicine and reconstructive surgery specialist at Mayo Clinic. "The condition can be debilitating due to social isolation, depression, loss of self-esteem and self-confidence.

"If a patient does not improve through use of less invasive techniques, our only option has been a colostomy," says Dr. Pettit, who performed the four surgeries. "This device now offers a new option that restores function, and we are happy to be able to offer it."

The operation itself lasts about 45 minutes and requires an overnight hospital stay.

Most patients with fecal incontinence -- a syndrome that involves unintentional loss of solid or liquid stool -- are women, and often the cause is childbirth, when the muscles and nerves near the anus are damaged, Dr. Pettit says.

When the system is implanted, the string of magnetic titanium beads is placed around the anal canal in the closed position. Increased intra-abdominal pressure opens the beads to allow for passage of stool. The magnets then spontaneously close.

The device works immediately after surgery and does not require any activation by the patient or adjustments by a physician, according to the manufacturer, Torax Medical Inc., in St. Paul, Minnesota.
-end-
Mayo researchers and clinicians who worked with Dr. Pettit on clinical use of the system are Heidi Chua, M.D., Anita Chen, M.D., and Chris DeStephano, M.D., M.P.H.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or http://newsnetwork.mayoclinic.org/.

Mayo Clinic

Related Mayo Clinic Articles:

Mayo Clinic researchers demonstrate value of second opinions
Many patients come to Mayo Clinic for a second opinion or diagnosis confirmation before treatment for a complex condition.
Mayo Clinic researchers clarify chemo resistance, and perhaps a new therapy
Mayo Clinic scientists have identified a specific protein implicated in drug resistance, as well as a possible therapeutic tool.
Mayo Clinic researchers identify therapy
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma.
Mayo Clinic researchers uncover new agents
Mayo Clinic researchers have uncovered three new agents to add to the emerging repertoire of drugs that aim to delay the onset of aging by targeting senescent cells -- cells that contribute to frailty and other age-related conditions.
Mayo Clinic: Reversing physician burnout, using nine strategies to promote well-being
Researchers at Mayo Clinic have been documenting the rise and costs of physician burnout for more than a decade.
Mayo Clinic and Massachusetts Institute of Technology receive grant
Mayo Clinic and the Massachusetts Institute of Technology have been awarded a five-year, $9.7 million grant from the National Cancer Institute to support a Physical Sciences-Oncology Center (PS-OC).
Mayo Clinic and ASU to form collaborative research teams
Mayo Clinic and Arizona State University's research leadership announce the launch of a new grant program that will team up research scientists and clinicians from both institutions to develop transformative solutions for patients.
Mayo Clinic studying genomics of antiplatelet heart medication
TAILOR-PCI, which began in 2013 with study teams at 15 hospitals in the US, Canada and South Korea and plans to enroll 5,270 patients, just received an additional $7 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health, to complete the study.
Mayo Clinic introduces precision medicine in psychiatry
Mayo Clinic is highlighting the potential merits of using precision medicine in prescribing antidepressants.
Mayo clinic first to implant device to solve fecal incontinence
JACKSONVILLE, Fla. -- A clinical team on Mayo Clinic's Florida campus is the first to offer four patients with long-term fecal incontinence a new and potentially long-lasting treatment -- a small band of interlinked magnetic titanium beads on a titanium string that successfully mimics the function of the anal sphincter.

Related Mayo Clinic Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...